21518460

Source:http://linkedlifedata.com/resource/pubmed/id/21518460

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024117, umls-concept:C0036043, umls-concept:C2699757
pubmed:dateCreated	2011-5-23
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00358436, http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00363896
pubmed:abstractText	The long-term efficacy and safety of aclidinium bromide, a novel, long-acting muscarinic antagonist, were investigated in patients with moderate to severe chronic obstructive pulmonary disease (COPD).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-11866001, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-12114338, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-12728159, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-15693640, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-16055882, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-16144890, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-16507855, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-16844726, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-17136966, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-17136969, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-17136971, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-17166984, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-17507545, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-18060091, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-18238951, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-18686739, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-18836213, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-19640353, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-19651504, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-19683590, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-19710368, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-20044242, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-20093184, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-20525722, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-20573081, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-21311692, http://linkedlifedata.com/resource/pubmed/commentcorrection/21518460-8499054
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101090633
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/(3R)-3-((hydroxy(di-2-thienyl)acetyl..., http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/Muscarinic Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Tropanes
pubmed:status	MEDLINE
pubmed:issn	1465-993X
pubmed:author	pubmed-author:AgustiAlvarA, pubmed-author:BatemanEric DED, pubmed-author:CaractaCynthiaC, pubmed-author:ChanezPascalP, pubmed-author:DonohueJames FJF, pubmed-author:FabbriLeonardoL, pubmed-author:GilEsther GarciaEG, pubmed-author:GrossNicholas JNJ, pubmed-author:JonesPaul WPW, pubmed-author:LamarcaRosaR, pubmed-author:MagnussenHelgoH, pubmed-author:RennardStephen ISI
pubmed:issnType	Electronic
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	55
pubmed:meshHeading	pubmed-meshheading:21518460-Administration, Inhalation, pubmed-meshheading:21518460-Aged, pubmed-meshheading:21518460-Bronchodilator Agents, pubmed-meshheading:21518460-Double-Blind Method, pubmed-meshheading:21518460-Drug Administration Schedule, pubmed-meshheading:21518460-Dry Powder Inhalers, pubmed-meshheading:21518460-Dyspnea, pubmed-meshheading:21518460-Europe, pubmed-meshheading:21518460-Female, pubmed-meshheading:21518460-Forced Expiratory Volume, pubmed-meshheading:21518460-Health Status, pubmed-meshheading:21518460-Humans, pubmed-meshheading:21518460-Logistic Models, pubmed-meshheading:21518460-Lung, pubmed-meshheading:21518460-Male, pubmed-meshheading:21518460-Middle Aged, pubmed-meshheading:21518460-Muscarinic Antagonists, pubmed-meshheading:21518460-North America, pubmed-meshheading:21518460-Pulmonary Disease, Chronic Obstructive, pubmed-meshheading:21518460-Quality of Life, pubmed-meshheading:21518460-Questionnaires, pubmed-meshheading:21518460-Severity of Illness Index, pubmed-meshheading:21518460-Time Factors, pubmed-meshheading:21518460-Treatment Outcome, pubmed-meshheading:21518460-Tropanes
pubmed:year	2011
pubmed:articleTitle	Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease.
pubmed:affiliation	St George's, University of London, London, UK. pjones@sgul.ac.uk
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study